trending Market Intelligence /marketintelligence/en/news-insights/trending/cxo3lot9lhevul-gudukfw2 content esgSubNav
In This List

Orexo CFO to leave and join Bavarian Nordic

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Orexo CFO to leave and join Bavarian Nordic

Bavarian Nordic A/S appointed Henrik Juuel as executive vice president and CFO.

Juuel plans to join the Danish company in the fourth quarter of 2018. He is the CFO of Orexo AB (publ), a specialty pharmaceutical company based in Sweden.

Orexo said Juuel's last working day with the company will be in November and it has started the search for a replacement. Juuel has been the CFO of Orexo since 2013.

Denmark-based Bavarian Nordic is a biotechnology company, which develops, manufactures and commercializes a portfolio of novel vaccines for the prevention and treatment of life-threatening infectious diseases and cancer.